Overview
- 64 inspections across 63 sites are on record.
- 68 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2017-05-26.
At a glance
Inspections
64
Sites
63
Observations
68
Career since
Feb 2008
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Hainan Shuangcheng Pharmaceuticals Co., Ltd. | 26 May 2017 | Human Drugs | On file |
| Swiss Pharmaceutical Company Ltd | 12 May 2017 | Human Drugs | On file |
| BGP Healthcare Private Limited | 25 Aug 2016 | Human Drugs | |
| Asence Pharma Private Limited | 19 Aug 2016 | Human Drugs | On file |
| Sun Pharma Advanced Research Company Ltd | 1 Jul 2015 | Human Drugs |
Sites inspected
Hainan Shuangcheng Pharmaceuticals Co., Ltd.Haikou, China1 insp.
Swiss Pharmaceutical Company LtdTai Nan Shi, Taiwan1 insp.
BGP Healthcare Private LimitedAnklesvar, India1 insp.
Asence Pharma Private LimitedAnkleshwar, India1 insp.
Sun Pharma Advanced Research Company LtdVadodara, India1 insp.
Co-investigators
Investigators who share inspections with this person.
Debra I Love6 shared
Nadeem I Chaudhry4 shared
Jose A Cruz Gonzalez4 shared
Marvin D Jones4 shared
Simone E Pitts4 shared
Dawn E Barkans4 shared
Margaret M Annes4 shared
John A Gonzalez3 shared
Marijo B Kambere3 shared
Michael A Taylor3 shared
Full investigator report
Get the verbatim findings behind Katherine Szestypalow's 68 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site